UBS Group’s ETRACS 2x Leveraged US Dividend Factor TR ETN SCDL Stock Holding History

UBS Group’s Portfolio SCDL Stock Details SCDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.07M	Sell	143,500 -1,700	-1%	-$81.1K	﹤0.01%	3708
2025 Q4	$5.75M	Buy	+145,200	New	+$5.59M	﹤0.01%	3890
2025 Q3	–	Sell	-200	Closed	-$7.33K	–	10854
2025 Q2	$7.33K	Buy	+200	New	+$7.04K	﹤0.01%	9026
2024 Q3	–	Sell	-73	Closed	-$2.57K	–	9993
2024 Q2	$2.57K	Hold	73	–	–	﹤0.01%	8332
2024 Q1	$2.76K	Sell	73 -85	-54%	-$2.95K	﹤0.01%	7835
2023 Q4	$5.33K	Buy	+158	New	+$4.7K	﹤0.01%	7793
2023 Q1	–	Sell	-246	Closed	-$8.29K	–	10277
2022 Q4	$8.29K	Buy	246 +43	+21%	+$1.39K	﹤0.01%	8790
2022 Q3	$5K	Buy	203 +137	+208%	+$4.32K	﹤0.01%	9220
2022 Q2	$2K	Buy	+66	New	+$2.28K	﹤0.01%	9607

Other funds holding SCDL

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

UBS Group's SCDL Position: Q1 2026 in Review

UBS Group reduced its ETRACS 2x Leveraged US Dividend Factor TR ETN (SCDL) stake by 1.2% in Q1 2026, selling an estimated $81.1K and leaving 143,500 shares worth $7.07M. The position accounts for ﹤0.01% of the portfolio, ranked #3708.

UBS Group first reported a position in SCDL in Q2 2022 and has held it in 9 quarters since. 2 funds tracked by Wall St. Rank hold SCDL as of Q1 2026.

UBS Group held 143,500 shares of ETRACS 2x Leveraged US Dividend Factor TR ETN worth $7.07M as of Q1 2026.
UBS Group sold 1,700 ETRACS 2x Leveraged US Dividend Factor TR ETN shares in Q1 2026, an estimated $81.1K.
ETRACS 2x Leveraged US Dividend Factor TR ETN made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3708 holding.
UBS Group first reported a position in ETRACS 2x Leveraged US Dividend Factor TR ETN in Q2 2022 and has held it in 9 quarters since.
2 funds tracked by Wall St. Rank held ETRACS 2x Leveraged US Dividend Factor TR ETN as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.